Cancer clinical trials in the region Nouvelle-Aquitaine

400 currently recruiting clinical trials
Region Nouvelle-Aquitaine

Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic HER2 1 Targeted therapy
Systemic Treatment-Naive
1 recruiting site
Daiichi Sankyo
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 1
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access Breast cancer
HER2 Negative HR Positive Locally Advanced Metastatic PIK3CA None Hormone therapy Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
1 recruiting site
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
1 recruiting site
Janssen
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Localized Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
1 recruiting site
AstraZeneca
Early Access Acute leukemia
Acute lymphoblastic leukemia (ALL) B-cell (B-ALL) CD19 None Chemotherapy
Ph+ (Philadelphia chromosome positive) Systemic Treatment-Naive
1 recruiting site
Amgen
Early Access Acute leukemia
Acute lymphoblastic leukemia (ALL) B-cell (B-ALL) CD19 None Chemotherapy
Ph+ (Philadelphia chromosome positive) Systemic Treatment-Naive
1 recruiting site
Amgen
Early Access Ovarian / Fallopian tubes / Peritoneum cancer
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Serous high grade carcinoma (HGSOC) Greater than or equal to 75% 1 2 3 or more Recurrence within 6 months after platinum-based tr... Chemotherapy Chemotherapy
Systemic Treatment-Naive Systemic Treatment-Naive
1 recruiting site
Abbvie
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
1 recruiting site
AstraZeneca